Immuno-metabolic interfaces in cardiac disease and failure

Area of Science:

• Cardiovascular Medicine
• Immunology
• Metabolic Science

Background:

• Cardiovascular diseases (CVDs) involve complex interactions between the cardiovascular system, metabolism, and inflammation.
• Heart failure (HF) is a significant manifestation of CVDs where these interactions are critically implicated.
• The immuno-metabolic interface, governing how immune cells and metabolism influence each other, is central to disease pathophysiology.

Purpose of the Study:

• To provide a comprehensive overview of the interrelation between inflammation and metabolism in CVDs.
• To elucidate the role of metabolism in immune cell function and how inflammation affects systemic and cardiac metabolism.
• To discuss the implications of a disrupted immuno-metabolic interface in the development and progression of heart failure.

Main Methods:

• Literature review and synthesis of current research on immuno-metabolic interactions in cardiovascular health and disease.
• Analysis of fundamental aspects of inflammation-metabolism interplay, including immune cell metabolism.
• Examination of how inflammation modulates systemic and cardiac metabolic processes.

Main Results:

• Metabolism is crucial for immune cell function, impacting inflammatory responses.
• Inflammation significantly alters systemic and cardiac metabolic pathways.
• Disruption of the immuno-metabolic interface is a key driver in the pathogenesis of cardiovascular diseases, particularly heart failure.

Conclusions:

• The intricate connection between inflammation and metabolism is fundamental to cardiovascular disease, especially heart failure.
• Targeting the immuno-metabolic interface presents novel therapeutic opportunities for cardiovascular medicine.
• Emerging technologies and therapeutic strategies offer promising avenues for future cardiovascular disease management.